Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

Post by lscfaon Dec 18, 2021 8:38am
200 Views
Post# 34243140

Busted

Busted

VANCOUVER, BCDec. 17, 2021 /CNW/ - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU) (OTCQB: NRXCF) (FSE: 1N9), announces that as a result of a review by the British Columbia Securities Commission it has refiled its management discussion & analysis for the six- and nine-month periods ended June 30, 2021 and September 30, 2021(collectively, the "MD&A").  The refiled MD&A includes additional disclosure regarding a one-time financial loss incurred by the Company, and which was already reflected in the accompanying interim financial statements for these periods. No changes to the interim financial statements were made in connection with the refiling of the MD&A. 

Copies of the refiled MD&A are available for review under the profile for the Company on SEDAR (www.sedar.com).

 
<< Previous
Bullboard Posts
Next >>